Qiang Xia

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation

Hai Li, Qiang Xia, Bo Zeng et al. · Journal of Hepatology · 2015 · 102 citations

Cirrhotic Patients, Hepatology, Acute Decompensation +8

Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling

Jun Li, Yahui Wang, Mingze Ma et al. · EBioMedicine · 2019 · 101 citations · Full text

Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy

Ziyi Li, Rhea Pai, Saurabh Gupta et al. · Nature Cancer · 2024 · 72 citations · Full text

Hepatology, Hepatocellular Carcinoma, Oncogenic Agent +6

Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 Pathway

Yankai Wen, Dechun Feng, Hailong Wu et al. · International Journal of Biological Sciences · 2015 · 70 citations · Full text

Opn Knockout, Sclerostin, Il-6/stat3 Pathway +22